ROSEVILLE, Minn., Sept. 22, 2022 /PRNewswire/ — Calyxt, Inc. (NASDAQ: CLXT) (“Calyxt”), a plant-based synthetic biology company, today announced that its Board of Directors is evaluating potential strategic alternatives to maximize shareholder value. As part of the process, the Board is…
Related Posts
Agricultural Adjuvants Global Market Outlook 2022-2027: A $4,786.5 Million Market by 2027, with CAGR of 6.43%
DUBLIN, July 4, 2022 /PRNewswire/ — The “Agricultural Adjuvants Market – A Global Market and Regional Analysis: Focus on Product,…
Steel Dynamics Reports Record Second Quarter 2022 Results
FORT WAYNE, Ind., July 20, 2022 /PRNewswire/ — Second Quarter 2022 Performance Highlights: Record steel shipments of 3.1 million tons…
Outlook on the Ozone Generator Global Market to 2027 – Increased Demand from Municipal Water Treatment Plants is Driving Growth
DUBLIN, July 25, 2022 /PRNewswire/ — The “Global Ozone Generator Market, By Technology (Ultraviolet, Cold Plasma, Corona Discharge, Electrolytic), By…